# InMode Ltd. (INMD)

> Source: Nexqual · https://nexqual.com/INMD · data as of 2026-10-29 20:00 UTC · cite as "Nexqual, InMode Ltd. (INMD), nexqual.com/INMD" · informational, not investment advice.

**Price:** USD 13.51 (+1.05% on the day) · last close of Oct 29, 2026; US market closed, not a live price. Prev close 13.37 · day 13.36–13.55 · 52w 12.72–16.67 · market cap $777M · NMS

## Key facts
- 1 of 80 tracked superinvestors hold INMD (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (5 analysts), mean target USD 16.17 (range 15–17).
- Total return with dividends: 1Y -9.1% vs S&P 500 +14.8%; 5Y -85.7% vs S&P 500 +79.1%.
- Next earnings: 2026-11-11, EPS estimate USD 0.32, revenue estimate $90.8M. All companies reporting that day: https://nexqual.com/earnings/2026-11-11
- Dividend: INMD paid no cash dividend in the last five years.
- Short interest: 4.37% of float (as of 2026-10-15), 4.7 days to cover.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold INMD. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Sarah Ketterer | Causeway Capital Management | <0.01% | $266K | Reduced -74.7% |

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 5 analysts; mean target USD 16.17 (low 15, high 17).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-30) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -9.1% | -85.7% |
| S&P 500 (SPY) | +14.8% | +79.1% |
| Per year | -9.2% | -32.2% |
| Volatility (annualized) | 29.7% | 46.3% |
| Max drawdown | -23.2% (Feb 2026→Mar 2026) | -86.0% (Oct 2021→Mar 2026) |

## Dividends
INMD paid no cash dividend in the last five years.

## Short interest
2,219,358 shares sold short, 4.37% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 2,358,545 shares (-5.9%). Days to cover: 4.7 (short shares ÷ average daily volume).

## Peers (Medical Devices)
INSP (Inspire Medical Systems, Inc.) USD 71.18 +0.30% · ESTA (Establishment Labs Holdings Inc) USD 68.41 -0.81% · BFLY (Butterfly Network, Inc.) USD 7.51 -3.84% · UFPT (UFP Technologies, Inc.) USD 293.3 +2.55% · TMDX (TransMedics Group, Inc.) USD 67.12 +0.33% · ALMR (Alamar Biosciences, Inc.) USD 34.04 -0.76%

## More
Full page: https://nexqual.com/INMD · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)


Other companies that name INMD in their own reports (relationship from INMD's side):

| Relationship | Company | Their filing | Sentence |
|---|---|---|---|
| partner | SBC Medical Group Holdings Inc (SBC) | 10-K 2026-03-27 | "Braun SE, Cynosure Lutronic, Evolus, Inc., Galderma S.A., Genesis Biosystems, Inc., Inmode Ltd., IRIDEX Corporation, Lumenis Be Ltd., Sinclair Pharma Limited, Stryker Corporation, and Surgery Partners…" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.32 | $0.34 | -4.7% | $90.8M | 5 |
| Next quarter (ends 2026-12-31) | $0.38 | $0.42 | -9.0% | $101.1M | 5 |
| Current fiscal year (ends 2026-12-31) | $1.30 | $1.32 | -2.0% | $370.3M | 5 |
| Next fiscal year (ends 2027-12-31) | $1.37 | $1.45 | -5.2% | $378.8M | 5 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-11-11): ±11.1%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 22 | 38.5% | ±11.1% |
| 2026-12-18 | 50 | 47.7% | ±11.8% |
| 2027-01-15 | 78 | 32.7% | ±15.4% |
| 2027-02-19 | 113 | 35.2% | ±18.1% |
| 2027-05-21 | 204 | 42.9% | ±25.5% |

## Earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.35 | $0.33 | Beat +6.1% | — |
| — | Quarter ended Mar 31, 2026 | $0.25 | $0.30 | Miss −16.7% | — |
| — | Quarter ended Dec 31, 2025 | $0.46 | $0.42 | Beat +9.5% | — |
| — | Quarter ended Sep 30, 2025 | $0.38 | $0.35 | Beat +8.6% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).